Shawn Gerstenberger (Public Health) was awarded a $296,109 grant from Gilead Sciences, Inc., which proposes routine opt-out HIV and syphilis testing for adult ED patients already receiving blood draws for clinical care.
Shawn Gerstenberger (Public Health) was awarded a $296,109 grant from Gilead Sciences, Inc., which proposes routine opt-out HIV and syphilis testing for adult ED patients already receiving blood draws for clinical care.
